Sign in

Estia Eichten

Director at VICORVICOR
Board

About Estia J. Eichten

Dr. Estia J. Eichten, age 78, has served as a director of Vicor since 1981, making him one of the longest-tenured independent directors on the board. A theoretical physicist, he is Distinguished Scientist Emeritus at Fermi National Accelerator Laboratory (since October 2019), having previously served there since 1981 and as Senior Scientist since 1989; he was earlier an Associate Professor of Physics at Harvard University. He holds both a B.S. and Ph.D. in Physics from MIT, is a Fellow of the American Physical Society and AAAS, and was co-recipient of the J. J. Sakurai Prize for Theoretical Particle Physics in 2011 .

Past Roles

OrganizationRoleTenureCommittees/Impact
Fermi National Accelerator LaboratorySenior Scientist; Distinguished Scientist Emeritus1981–present; Emeritus since Oct 2019 Deep technical expertise; perspective on technology trends
Harvard UniversityAssociate Professor of PhysicsEarlier (dates not specified) Academic credentials and scientific rigor
VLT, Inc. (wholly-owned subsidiary of Vicor)DirectorJul 2000–Aug 2020 Oversight of IP as prior majority owner of Vicor’s patents

External Roles

OrganizationRoleTenure/Status
American Physical SocietyFellowCurrent
American Association for the Advancement of Science (AAAS)FellowCurrent
J. J. Sakurai PrizeAward recipient (with collaborators)2011

Board Governance

  • Independence: The board determined Dr. Eichten is independent under Nasdaq rules; he serves on both the Audit Committee and Compensation Committee alongside other independent directors .
  • Committee assignments: Audit Committee member (chair: Jason L. Carlson) and Compensation Committee member (chair: Jason L. Carlson) .
  • Controlled company: Vicor is a “controlled company” due to CEO Patrizio Vinciarelli’s 79.6% voting power; the company relies on Nasdaq controlled-company exemptions (not majority independent board, non-independent involvement in nominations and executive compensation), while maintaining fully independent Audit and Compensation Committees .
  • Board leadership: Combined Chair/CEO; no Lead Independent Director; independent director executive sessions occur at each board meeting .
  • Attendance: In 2024, each director attended at least 75% of board and committee meetings; all directors attended the 2024 annual meeting. Board met 3 times; Audit Committee met 5 times; Compensation Committee met 5 times and acted by written consent 15 times .
  • Hedging policy: Vicor does not prohibit employees and directors from hedging the economic risk of owning company stock (potential alignment red flag) .
  • Clawback: A compensation recovery policy compliant with SEC/Nasdaq was adopted in 2023 for covered officers; director applicability is not stated .

Fixed Compensation

Component2024 Amount/DetailNotes
Annual cash retainer$30,000$7,500 per quarter for non-employee directors
Annual stock option grant6,081 optionsFormula: $200,000 ÷ closing share price on AGM date; granted 6/21/2024 at $32.89 exercise price
Grant date fair value (2024)$104,856Aggregate grant date fair value of director option award
Vesting schedule20% per year over five yearsStandard for director option grants
Meeting/committee feesNot disclosed/noneExpenses reimbursed; no separate chair fees disclosed for directors

Performance Compensation

Performance MetricWeighting/Role in Director PayNotes
None disclosedN/ADirector option grants are time-vested; no performance-based metrics disclosed for directors .

Other Directorships & Interlocks

CompanyRoleTenureNotes
VLT, Inc. (Vicor subsidiary)DirectorJul 2000–Aug 2020Subsidiary merged into Vicor in Aug 2020
Public company boardsNone disclosedNo current/prior public boards listed for Eichten
Committee interlocksNoneBoard reports no interlocks requiring disclosure under Item 407(e)(4)

Expertise & Qualifications

  • 44 years of board service at Vicor; deep understanding of products, organization, and technology evolution .
  • MIT-trained physicist; senior roles at Fermilab; recognized through APS/AAAS fellowships and the Sakurai Prize .
  • Provides “important perspectives on technology trends” and historical strategy context per board risk management discussion .

Equity Ownership

ItemAmountDetail
Total beneficial ownership945,684 sharesIncludes Common and Class B
Class B shares held690,700Convertible 1:1 into Common; 10 votes per share
Percent of Common Stock0.8%As of Mar 31, 2025
Percent of Class B Stock5.9%As of Mar 31, 2025
Voting power4.7%Aggregate voting power attributable to holdings
Options exercisable within 60 days12,572Included in beneficial ownership per SEC rules
Trust holdings12,145 CommonBelle S. Feinberg Memorial Trust; Eichten is trustee
Director options outstanding (as of 12/31/2024)23,207 optionsAggregate number outstanding; cumulative grant-date fair value $422,750
Pledging/HedgingHedging permitted; pledging not disclosedCompany does not prohibit director hedging

Governance Assessment

  • Positives: Independent service on both key committees (Audit and Compensation), with fully independent membership per Nasdaq requirements; audit committee chaired by a financial expert (Carlson) with Eichten as member; consistent attendance ≥75%; significant equity ownership aligns interests to an extent .
  • Constraints: Controlled-company structure with 79.6% voting power held by CEO, combined Chair/CEO, and no Lead Independent Director reduce independent oversight leverage; Eichten’s very long tenure (44 years) may raise questions about independence in practice for some investors despite formal independence .
  • Red flags: Company permits director hedging, which can weaken alignment; option awards under the Vicor plans automatically accelerate upon change of control, potentially misaligning incentives around M&A outcomes; no director stock ownership guidelines disclosed .
  • Conflicts: No related-party transactions disclosed for Eichten. Related-party arrangements exist for other directors (e.g., D’Amico consulting; Anderson’s IceMOS license), with Audit Committee oversight per policy .

Additional context: Say-on-pay is triennial; 2023 SOP was approved, next SOP scheduled for 2026. While SOP focuses on executive compensation, it informs overall governance sentiment .